HLS Therapeutics (HLTRF) News Today $3.83 0.00 (0.00%) As of 09/15/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort InterestBuy This Stock HLTRF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period HLS Therapeutics Secures New Credit Agreement for Financial FlexibilityAugust 20, 2025 | tipranks.comHLS Therapeutics Inc.: Strategic Positioning and Growth Potential Justify Buy RatingMay 11, 2025 | tipranks.comHLS Therapeutics and Esperion partner to commercialise oral cardiovascular medicinesMay 9, 2025 | msn.comHLS Therapeutics Inc (HLTRF) Q1 2025 Earnings Call Highlights: Strong Sales Growth and ...May 9, 2025 | finance.yahoo.comHLS Therapeutics partners with Esperion Therapeutics to commercialize NEXLETOL® and NEXLIZET® in CanadaMay 8, 2025 | finance.yahoo.comHLS Therapeutics Partners with Esperion to Bring Cardiovascular Treatments to CanadaMay 8, 2025 | tipranks.comHLS Therapeutics to Present at the 2025 Bloom Burton & Co. Healthcare Investor ConferenceApril 28, 2025 | finance.yahoo.comHLS Therapeutics to Present at 2025 Healthcare Investor ConferenceApril 28, 2025 | tipranks.comHLS Therapeutics to Host Q1 2025 Financial Results Conference CallApril 24, 2025 | finance.yahoo.comHLS Therapeutics Inc.'s (TSE:HLS) biggest owners are individual investors who got richer after stock soared 18% last weekMarch 22, 2025 | finance.yahoo.comHLS Therapeutics to Host Fiscal 2024 Financial Results Conference CallFebruary 27, 2025 | finance.yahoo.comHLS Therapeutics to Host Q3 Fiscal 2024 Financial Results Conference CallOctober 24, 2024 | ca.finance.yahoo.comHLS Therapeutics GAAP EPS of -$0.18, revenue of $14.52MAugust 9, 2024 | msn.comAn Intrinsic Calculation For HLS Therapeutics Inc. (TSE:HLS) Suggests It's 44% UndervaluedMay 9, 2024 | finance.yahoo.comHLS Therapeutics to Host Q1 Fiscal 2024 Financial Results Conference CallApril 25, 2024 | finance.yahoo.comHLS Therapeutics to Host Q4 and Fiscal 2023 Financial Results Conference CallFebruary 29, 2024 | finance.yahoo.comHLS Therapeutics IncFebruary 6, 2024 | morningstar.comMHLS Therapeutics (TSE:HLS) shareholders have endured a 78% loss from investing in the stock three years agoDecember 5, 2023 | finance.yahoo.comHLS Therapeutics to Host Q3 Fiscal 2023 Financial Results Conference CallOctober 26, 2023 | finance.yahoo.comHLS Therapeutics to Present at H.C. Wainwright's 25th Annual Global Investment ConferenceSeptember 6, 2023 | finance.yahoo.comHLS Therapeutics Announces Q2 Fiscal 2023 Financial ResultsAugust 10, 2023 | finance.yahoo.comHLS Therapeutics Chairman to Retire; Polar Nominee to Join BoardJune 8, 2023 | marketwatch.comHLS Therapeutics Inc (HLS) Receives a Buy from ClarusMay 12, 2023 | markets.businessinsider.comHLS Therapeutics to Host Q1 Fiscal 2023 Financial Results Conference CallMay 3, 2023 | finance.yahoo.comHLS Therapeutics to Present at the 2023 Bloom Burton & Co. Healthcare Investor ConferenceApril 21, 2023 | finance.yahoo.comHLS Therapeutics Appoints Craig Millian CEO to Head CompanyApril 17, 2023 | marketwatch.comHLS Therapeutics earnings: here's what Wall Street expectsMarch 15, 2023 | markets.businessinsider.comHLS Therapeutics to Host Q4 and Fiscal 2022 Financial Results Conference CallMarch 2, 2023 | finance.yahoo.comShareholders in HLS Therapeutics (TSE:HLS) are in the red if they invested three years agoJanuary 12, 2023 | finance.yahoo.comHLS Therapeutics Inc. (HLTRF)January 1, 2023 | finance.yahoo.comHLS Therapeutics Inc. (TSE:HLS): When Will It Breakeven?December 14, 2022 | finance.yahoo.comHLS Therapeutics Announces Q3 Fiscal 2022 Financial Results and Renewal of Normal Course Issuer BidNovember 10, 2022 | finance.yahoo.comHLS Therapeutics Stock (OTC:HLTRF), Guidance and ForecastOctober 5, 2022 | benzinga.comHLS Therapeutics Announces Updates to its Credit AgreementOctober 3, 2022 | finance.yahoo.comHLS Therapeutics to Host Q1 Fiscal 2022 Financial Results Conference CallApril 28, 2022 | finance.yahoo.comHLS Therapeutics Completes Letter of Intent With Canada Alliance on VascepaApril 26, 2022 | marketwatch.comHLS Therapeutics completes negotiations with pCPA for Vascepa®April 26, 2022 | finance.yahoo.comHLS Therapeutics to Host Q4 & Fiscal 2021 Financial Results Conference CallMarch 14, 2022 | finance.yahoo.comHLS Therapeutics to Present at the Sidoti Investor ConferenceJanuary 12, 2022 | finance.yahoo.comSaladax Biomedical and HLS Therapeutics Strengthen Partnership With an Exclusive Distribution Agreement for CanadaNovember 18, 2021 | apnews.comAHLS Therapeutics to Present at the Stifel 2021 Virtual Healthcare ConferenceNovember 11, 2021 | finance.yahoo.comHLS Therapeutics Inc.'s (TSE:HLS) Shift From Loss To ProfitNovember 8, 2021 | finance.yahoo.comHLS Therapeutics to Participate in Two Virtual Non-Deal RoadshowsOctober 4, 2021 | finance.yahoo.comIs HLS Therapeutics a Can’t-Miss Buy?September 29, 2021 | msn.comHLS Therapeutics to Present at the Canaccord Genuity 41st Annual Growth ConferenceAugust 4, 2021 | finance.yahoo.comHLS Therapeutics (TSE:HLS) Shareholders Have Enjoyed A 98% Share Price GainAugust 3, 2021 | finance.yahoo.comHLS Therapeutics to Host Q2 2021 Financial Results Conference CallJuly 22, 2021 | finance.yahoo.com Get HLS Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HLTRF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HLTRF Media Mentions By Week HLTRF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HLTRF News Sentiment▼1.000.92▲Average Medical News Sentiment HLTRF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HLTRF Articles This Week▼10▲HLTRF Articles Average Week Get the Latest News and Ratings for HLTRF and Related Stocks Enter your email address to receive the latest news and analysts' ratings for HLS Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies TGIFF News FFNTF News ABSCF News LBTSF News AZFL News ERBB News AVTBF News AVCNF News BIOYF News CBGL News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:HLTRF) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored“Godfather of AI’s” dire warningAI pioneer Geoffrey Hinton warns the technology could create massive unemployment and widen inequality, but Po...Porter & Company | SponsoredAmerica’s most terrifying chart?MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored(Please Ignore if Already Rich)Discover how to get access to a weekly livestream with TWO Pro Traders for a full month… And learn their un...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HLS Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HLS Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HLTRF Stock Alerts